HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Single Identity Test For Botanicals "Makes Sense" - Israelsen

This article was originally published in The Tan Sheet

Executive Summary

The use of multiple tests to confirm the identity of botanical ingredients is inappropriate, especially for small manufacturers of dietary supplements, Utah Natural Products Alliance Executive Director Loren Israelsen told FDAers at a public meeting on supplement GMPs in Salt Lake City, Utah Sept. 28.

You may also be interested in...

Supplement Manufacturing Practices Survey Proposed By FDA

FDA is proposing to conduct a survey of dietary supplement companies' existing manufacturing practices for use in developing its proposed rule on industry-wide GMP standards, the agency says in an Oct. 6 Federal Register notice.

Supplement Defect Action Levels To Follow GMP Reg - FDAer

The establishment of defect action levels (DALs) for dietary supplement ingredients likely will be handled separately from FDA's pending proposed rule on Good Manufacturing Practice standards for supplements, FDA Consumer Safety Officer Karen Strauss told small business reps at a GMPs meeting in Salt Lake City, Utah Sept. 28.

GMP Identity Test Exemption For Small Ingredient Batches Suggested To FDA

Batches of raw plant materials under 500 lbs. should be exempt from multiple identity tests that would be required under future GMP standards for dietary supplements, American Herbal Products Association rep Beth Lambert said at an FDA meeting in Las Vegas July 12.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts